September 09, 2004
Omnicare of Maine will pay $1.08 million to the state of Maine to settle charges that it switched patients from prescribed tablets of an anti-ulcer drug to unprescribed capsules. The state said that the switches were initiated specifically to increase company revenue.
The Attorney General’s Office issued a press release on August 27, 2004.